Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy

Claudia Bruedigam, Frederik Otzen Bagger, Florian H. Heidel, Catherine Paine Kuhn, Solene Guignes, Axia Song, Rebecca Austin, Therese Vu, Erwin Lee, Sarbjit Riyat, Andrew S. Moore, Richard B. Lock, Lars Bullinger, Geoffrey R. Hill, Scott A. Armstrong, David A. Williams, Steven W. Lane